搜索结果

Search Results for " cystatin c "

抑制剂 & 化合物

TargetMol 试剂盒

重组蛋白

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Form	Specificity Of Inhibition
CEPY-0003	Human Cystatin C/CST3 ELISA Pair Set Human Cystatin C/CST3 ELISA 抗体对
CEKY-0003	Human Cystatin C/CST3 ELISA Kit Human Cystatin C/CST3 ELISA 试剂盒

TargetMol 试剂盒

Human Cystatin C/CST3 ELISA 抗体对

Cat.No: CEPY-0003

Human Cystatin C/CST3 ELISA 试剂盒

Cat.No: CEKY-0003

Cat. No.	Product Name	Target	Signaling Pathways
T80722	Z-LVG
	Z-LVG为一种不可逆半胱氨酸蛋白酶抑制剂，作为半胱抑素C的三肽衍生物，其可抑制病毒复制，应用于病毒相关疾病研究。

化合物

Species：

Expression System：

Tag：

Cat. No.	Product Name	Species	Expression System
TMPY-00767	Cystatin C Protein, Human, Recombinant (His) ARMD11,cystatin C	Human	HEK293 Cells
	Cystatin C Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 14.8 kDa and the accession number is A0A0K0K1J1.
TMPY-02056	Cystatin C Protein, Rat, Recombinant (His) cystatin C	Rat	HEK293 Cells
	Cystatin C Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 14.7 kDa and the accession number is P14841-1.
TMPY-01370	Cystatin C Protein, Mouse, Recombinant (His) cystatin C,CysC	Mouse	HEK293 Cells
	Cystatin C Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 15 kDa and the accession number is P21460.
TMPY-00640	Cystatin C Protein, Human, Recombinant ARMD11,cystatin C	Human	HEK293 Cells
	Cystatin C Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 13.3 kDa and the accession number is AAA52164.1.
TMPJ-00027	CST3 Protein, Human, Recombinant (Mammalian) Post-γ-globulin,Neuroendocrine basic polyp...	Human	HEK293 Cells
	CST3 Protein, Human, Recombinant (Mammalian) is expressed in HEK293 mammalian cells. The predicted molecular weight is 15 KDa and the accession number is P01034.
TMPY-01644	Cystatin S Protein, Human, Recombinant (His) MGC71923,cystatin S,CST4	Human	HEK293 Cells
	Cystatin-S, also known as Cystatin-4, Salivary acidic protein 1, Cystatin-SA-III and CST4, is a secreted protein which belongs to thecystatin family. Cystatin-4 / CST4 is expressed in submandibular and sublingual saliva but not in parotid saliva (at protein level). It is also expressed in saliva, tears, urine and seminal fluid. The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while oth...
TMPY-02070	Cystatin SN Protein, Human, Recombinant (His) CST1,cystatin SN	Human	HEK293 Cells
	Cystatin-SN, also known as Cystain-SA-I, Cystatin-1, Salivary cystatin-SA-1 and CST1, is a secreted protein which belongs to thecystatin family. The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. Cystatin-SN / CST1 is expressed in submandibular and sublingual saliva but not in parotid saliva (at protein level). Cy...
TMPK-01450	HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi), Biotinylated KRAS1,MHC,K-RAS4B,KRAS,CFC2,K-RAS...	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01456	HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Tetramer Protein, Human, MHC (His & Avi) KRAS2,NS,MHC,C-K-RAS,KRAS1,K-RAS2A,K-RAS2B...	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01451	HLA-C 03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi) NS3,K-RAS4A,K-Ras 2,NS,KRAS1,RASK2,MHC,KI-RAS,KRAS,...	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.